• About us
• Contact

Advertisement

Organisation › Details

Abzena Ltd. (since 2018)

Abzena is a leading partner research organization which offers discovery, design, development and cGMP manufacture of biologics, bioconjugates and complex or highly potent small molecules to the global biopharmaceutical industry. From its facilities in the UK and US the company provides its customers with concept to clinic solutions. Abzena is owned by Welsh, Carson, Anderson & Stowe, one of the world’s leading private equity investors. *

 

	Start	2014-07-10 renamed
	Group	Abzena (Group)
	Predecessor	Abzena plc (AIM: ABZA)
	Industry	biopharmaceutical
	Industry 2	drug development
	Person	Stober, Matthew (Matt) (Abzena 202306 CEO)
	Person 2	Castellano, Thomas (Abzena 202306– CFO before Catalent + Lehman Brothers + Cendant Corp)
	Region	Cambridge, Cambridgeshire
	Country	United Kingdom (GB)
	City	n. a. Cambridge, Cambridgeshire
		Address record changed: 2022-02-01
Basic data	Employees	D: 101 to 500 (2018-03-30)
	Currency	GBP
	Annual sales	21,950,000 (revenues, consolidated (2017/18) 2018-03-31)
	Profit	-14,161,000 (2018-03-31)
	Cash	6,785,000 (2013-03-31)
		* Document for »About Section«: Abzena Ltd.. (2/1/22). "Press Release: Abzena Appoints Kevin Lundquist as Chief Financial Officer". Cambridge & San Diego, CA.
		Record changed: 2023-07-10

Advertisement

More documents for Abzena (Group)

• [1] Abzena Ltd.. (6/6/23). "Press Release: Abzena Appoints Thomas Castellano as Chief Financial Officer". San Diego, CA....
• [2] Abzena Ltd.. (3/31/22). "Press Release: Abzena Secures $65 Million in Additional Funding to Accelerate Growth and Expand Capacity". San Diego, CA....
• [3] Abzena Ltd.. (2/1/22). "Press Release: Abzena Appoints Kevin Lundquist as Chief Financial Officer". Cambridge & San Diego, CA....
• [4] Abzena Ltd.. (1/20/22). "Press Release: Abzena Appoints Jim Kennamer as SVP and Site Head of North Carolina". Cambridge & San Diego, CA....
• [5] Abzena Ltd.. (7/28/20). "Press Release: Abzena Receives Growth Capital Investment from Newly Launched Biospring Partners". Cambridge, Bristol, PA & San Diego, CA....
• [6] Abzena plc. (8/16/18). "Press Release: Recommended Cash Offer for Abzena plc [NOT FOR RELEASE WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION]"....
• [7] Abzena plc. (8/16/18). "Press Release: Update on Partial Monetisation of Abzena Inside Portfolio". Cambridge....
• [8] Abzena plc. (7/2/18). "Press Release: Abzena and Telix Sign Strategic Manufacturing and Bioconjugation Agreement". Cambridge & Melbourne....
• [9] Abzena plc. (9/19/17). "Press Release: Abzena Appoints Lotta Ljungqvist as Non-Executive Director". Cambridge....
• [10] Abzena plc. (9/14/17). "Press Release: Trading Update". Cambridge....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.